“Position Canada as an attractive destination for the conduct of clinical trials in the global marketplace, by providing international companies with information on Canada’s clinical trials assets through a comprehensive, unique, robust, searchable web-based database – the CCTAM (Canadian Clinical Trials Asset Map) .”
THE CANADIAN CLINICAL TRIALS ASSET MAP (CCTAM)
The CCTAM is a unique, robust, searchable web-based database designed to communicate Canada’s clinical research strengths to all stakeholders, including clinical trial sponsors. Visit CCTAM to learn more about this initiative.
CASE STUDY – CANADA: A WORLD LEADING LOCATION TO CONDUCT CLINICAL TRIALS
Canada is a world leading location for pharmaceutical and medical device companies to conduct their clinical trials. Both publicly available information and testimonials from leading global companies doing research in Canada show why many companies choose Canada for their clinical development projects based on its unique combination of quality and efficiency.
Clinical trial investments in Canada provide the greatest returns by producing high quality, timely research that generate a robust evidence package in support of new product commercialization. In addition, the prospects of the clinical trials industry in Canada hold the promise of continued growth, as its main players continue to innovate and cooperate in various collective ways and therapeutic areas to maintainthis competitive edge. Click here to access the case study.
Department of Foreign Affairs, Trade and Development (DFATD) & Canadian Clinical Trials Coordinating Centre (CCTCC): Investment Case on the Value of Conducting Clinical